30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Krognes

Track

Insider profile

Currently holds positions in Denali Therapeutics Inc, Corvus Pharmaceuticals Inc and Gritstone Oncology Inc

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
18 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Treasurer Denali Therapeutics Inc Nov. 1, 2015 -
Independent Director Corvus Pharmaceuticals Inc Jan. 1, 2016 -
Independent Director Gritstone Oncology Inc July 1, 2018 -
Chief Financial Officer Denali Therapeutics Inc Oct. 1, 2015 - Nov. 1, 2015
Steve Krognes's trades of Guardant Health Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04
S Sale
12,091 +21.1%
47.44
US$1,409,158 		12,091 +21.1% 47.44 US$1,409,158
2026-06-04 2026-06-04
PrS Proposed sale
17,078
444.10
US$1,078,154 		17,078 444.10 US$1,078,154
2025-01-08 2025-01-07
S Sale
58,254 +43.5%
438.78
US$3,931,025 		58,254 +43.5% 438.78 US$3,931,025
2025-01-07 2025-01-07
PrS Proposed sale
3,339
20.81
US$69,485 		3,339 20.81 US$69,485
2025-01-03 2024-12-31
PlS Planned sale
30,000 -50.8%
20.25
US$607,500 		30,000 -50.8% 20.25 US$607,500
2024-10-02 2024-09-30
PlS Planned sale
30,000 -50.8%
29.03
US$870,900 		30,000 -50.8% 29.03 US$870,900
2024-08-22 2024-08-20
S Sale
1,727 -5.0%
23.79
US$41,085 		1,727 -5.0% 23.79 US$41,085
2024-08-20 2024-08-20
PrS Proposed sale
1,727
23.79
US$41,085 		1,727 23.79 US$41,085
2024-07-03 2024-07-01
PlS Planned sale
100 -0.3%
22.80
US$2,280 		100 -0.3% 22.80 US$2,280
2024-07-03 2024-07-01
PlS Planned sale
29,900 -46.4%
22.12
US$661,388 		29,900 -46.4% 22.12 US$661,388
2024-07-01 2024-07-01
PrS Proposed sale
30,000
23.22
US$696,600 		30,000 23.22 US$696,600
2024-07-03 2024-06-13
S Sale
688 -1.3%
21.79
US$14,992 		688 -1.3% 21.79 US$14,992
2024-04-02 2024-04-01
PlS Planned sale
92,500 -66.1%
20.50
US$1,896,250 		92,500 -66.1% 20.50 US$1,896,250
2024-04-01 2024-04-01
PrS Proposed sale
92,500
20.52
US$1,898,100 		92,500 20.52 US$1,898,100
2024-02-15 2024-02-13
S Sale
2,750 -1.9%
17.29
US$47,548 		2,750 -1.9% 17.29 US$47,548
2024-02-13 2024-02-13
PrS Proposed sale
2,750
17.29
US$47,539 		2,750 17.29 US$47,539
2024-01-09 2024-01-05
S Sale
3,208 -2.2%
19.43
US$62,331 		3,208 -2.2% 19.43 US$62,331
2024-01-05 2024-01-05
PrS Proposed sale
3,208
19.43
US$62,326 		3,208 19.43 US$62,326
2023-08-23 2023-08-21
S Sale
1,419 -1.0%
22.60
US$32,069 		1,419 -1.0% 22.60 US$32,069
2023-08-21 2023-08-21
PrS Proposed sale
1,419
22.60
US$32,063 		1,419 22.60 US$32,063
2023-02-15 2023-02-13
S Sale
2,119 -1.5%
30.10
US$63,782 		2,119 -1.5% 30.10 US$63,782
2023-02-10 2023-02-08
S Sale
1,377 -0.9%
30.88
US$42,522 		1,377 -0.9% 30.88 US$42,522
2023-01-09 2023-01-05
S Sale
2,970 -2.0%
28.44
US$84,467 		2,970 -2.0% 28.44 US$84,467
2022-08-23 2022-08-19
S Sale
2,253 -1.5%
33.22
US$74,845 		2,253 -1.5% 33.22 US$74,845
2022-02-15 2022-02-11
S Sale
2,560 -2.1%
34.69
US$88,806 		2,560 -2.1% 34.69 US$88,806
2022-02-11 2022-02-09
S Sale
1,296 -1.0%
37.09
US$48,073 		1,296 -1.0% 37.09 US$48,073
2022-01-07 2022-01-05
S Sale
2,225 -1.8%
44.75
US$99,569 		2,225 -1.8% 44.75 US$99,569
2021-03-16 2021-03-15
PlS Planned sale
1,158 -0.1%
63.67
US$73,730 		1,158 -0.1% 63.67 US$73,730
2021-03-16 2021-03-15
PlS Planned sale
3,258 -0.4%
62.71
US$204,319 		3,258 -0.4% 62.71 US$204,319
2021-03-16 2021-03-15
PlS Planned sale
32,326 -3.6%
62.04
US$2,005,602 		32,326 -3.6% 62.04 US$2,005,602
2021-03-16 2021-03-15
PlS Planned sale
13,258 -1.5%
61.16
US$810,912 		13,258 -1.5% 61.16 US$810,912
2021-02-18 2021-02-16
PlS Planned sale
501 -0.1%
66.80
US$33,468 		501 -0.1% 66.80 US$33,468
2021-02-18 2021-02-16
PlS Planned sale
16,616 -1.8%
66.20
US$1,099,996 		16,616 -1.8% 66.20 US$1,099,996
2021-02-18 2021-02-16
PlS Planned sale
10,199 -1.1%
65.04
US$663,323 		10,199 -1.1% 65.04 US$663,323
2021-02-18 2021-02-16
PlS Planned sale
22,684 -2.4%
64.27
US$1,457,923 		22,684 -2.4% 64.27 US$1,457,923
2021-02-16 2021-02-11
S Sale
400 -0.4%
71.43
US$28,571 		400 -0.4% 71.43 US$28,571
2021-02-16 2021-02-11
S Sale
2,635 -2.6%
70.17
US$184,908 		2,635 -2.6% 70.17 US$184,908
2021-02-11 2021-02-09
S Sale
426 -3.2%
75.39
US$32,116 		426 -3.2% 75.39 US$32,116
2021-02-11 2021-02-09
S Sale
1,022 -7.1%
74.38
US$76,018 		1,022 -7.1% 74.38 US$76,018
2021-01-20 2021-01-15
PlS Planned sale
14,147 -1.5%
73.01
US$1,032,816 		14,147 -1.5% 73.01 US$1,032,816
2021-01-20 2021-01-15
PlS Planned sale
8,071 -0.8%
71.99
US$581,047 		8,071 -0.8% 71.99 US$581,047
2021-01-20 2021-01-15
PlS Planned sale
12,981 -1.3%
70.96
US$921,158 		12,981 -1.3% 70.96 US$921,158
2021-01-20 2021-01-15
PlS Planned sale
14,801 -1.5%
70.10
US$1,037,535 		14,801 -1.5% 70.10 US$1,037,535
2020-04-01 2020-03-30
S Sale
1,428 -0.1%
19.48
US$27,817 		1,428 -0.1% 19.48 US$27,817